Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects
Clinical trial NCT07588646 · COMPLETED
Trial details
- NCT number
- NCT07588646
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-29
- Primary completion
- 2021-11-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.